Viewing Study NCT03861403


Ignite Creation Date: 2025-12-24 @ 7:47 PM
Ignite Modification Date: 2025-12-29 @ 6:57 AM
Study NCT ID: NCT03861403
Status: TERMINATED
Last Update Posted: 2023-11-30
First Post: 2019-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors
Sponsor: Leap Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module